Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS market map / Vertical sector platforms / Healthcare and life sciences platforms / Provider revenue cycle, prior authorization and patient payments platforms

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Provider revenue cycle, prior authorization and patient payments platforms

Subscription platforms for provider-side revenue cycle outside general hospital financial ERP: charge capture, coding, denial management, prior authorization, patient estimates and payments, underpayment analytics, and healthcare payments/fintech. Excludes general hospital general-ledger and accounting ERP (out of scope for this submarket) and excludes clinical workflow platforms (niche 1).

Market size
$4.4B
$4.4B ($3.6B–$5.1B) · 2026 · Top-down
Growth
+11.5%
$7.6B by 2031
Attractiveness
— /100
for B2B sellers
Evidence
Low confidence
4 sources · Top-down
Level
Niche
Segmented by
Customer type
Buyers
Provider CFO, VP Revenue Cycle, VP Patient Financial Services, Controller
Buying centre
Finance-led buying centre: revenue cycle operations, IT integration, treasury/payments, and external RCM or clearinghouse partners; CFO sponsors
Buying triggers
  • Denial and denial-write-off spike
  • New payer contract or fee schedule change
  • Billing labour shortage and outsourced RCM contract renewal
  • Growth in self-pay and high-deductible patient mix
  • M&A or roll-up integration of billing systems
  • Automation and AI pilots in coding and prior authorization
Pains
  • Cost to collect and days in A/R
  • Billing staff churn and reliance on outsourced RCM
  • Long prior-authorization cycle times
  • Patient payment friction and bad debt
  • Fragmented data across EHR, clearinghouse and payer portals
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—

How this was sized

$4.4B ($3.6B–$5.1B) · 2026 · Top-down

In-scope 2026 pool ~$19.8bn (see niche 1 arithmetic from [7] and [10]). Niche = 22% of pool (assumption, Low confidence) = $4.4bn; range 18-26% = $3.6-5.1bn. Forecast 2031 at 11.52% [10] = $7.6bn; at 19.4% [7] = $10.7bn. [1] names Waystar among the healthcare vertical software issuers compared, and [4] reports embedded finance outgrowing subscription at category leaders, supporting the payments-linked revenue assumption.

Alongside it in Healthcare and life sciences platforms

// Sell into Provider revenue cycle, prior authorization and patient payments platforms

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.